期刊文献+

老年局部晚期非小细胞肺癌放化综合治疗的疗效分析 被引量:8

Research of Radio-chemotherapy in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的分析70岁以上老年局部晚期非小细胞肺癌的放化综合治疗疗效,探讨综合治疗的可行性。方法对61例70岁以上老年局部晚期非小细胞肺癌的治疗结果进行分析,并以同期治疗的75例<70岁的局部晚期非小细胞肺癌作为对照。结果≥70岁组中位生存时间为18个月,1、3、5年生存率分别为78.15%、18.47%、10.39%;<70岁组中位生存时间为19个月,1、3、5年生存率分别为69.44%、18.27%、8.08%,两组的生存率差异无统计学意义。除≥70岁组骨髓抑制明显外,其他副反应两组无明显差异。结论老年局部晚期非小细胞肺癌的治疗尚无统一方案,适当的给予综合治疗是可行的。 Objective To analye the treatment of locally advanced non-small cell lung cancer in the 70 years old and over to research the possibility of combined therapy. Methods Sixty-one cases with locally advanced non-small cell lung cancer were over 70 years old and 75 cases with locally advanced non-small cell lung cancer were younger than 70 years old whose results were analyzed. Results Of the over seventy years old patients, the median survival time was 18 months, and the 1,3,5 year overall survival rates was 78. 15%, 18.47%and 10. 39% ;The median survival and the 1,3.5 year overall survival rates of the〈70 years old patients were 19 months and 69. 44%, 18. 27% ,8. 08%. The survival rates were similar in two groups. Toxicity was similar except leucopenia in two groups. Conclusion There is no standard method for elderly patients with locally advanced non-small cell lung cancer. It is feasible to take the treatment of radiotherapy combined chemotherapy.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2008年第5期352-354,共3页 Cancer Research on Prevention and Treatment
关键词 非小细胞肺癌 放射疗法 化学疗法 老年人 Non-small cell lung cancer Radiotherapy Chemotherapy Aged
  • 相关文献

参考文献11

  • 1Fry W, Phillips, Menck H. Ten-year survey of lung cancer treatment and survival in hospitals in United State[J]. Cancer, 1999,86(9): 1867-1876.
  • 2Rocha Lima CM, Hernden JE 2^nd, Kosty M, et al. Therapy Choices Among Older Patients with Lung Carcinoma[J]. Cancer, 2002,94( 1 ) : 181-187.
  • 3欧广飞,王绿化,张红星,陈东福,肖泽芬,冯勤付,周宗玫,吕纪马,梁军,汪楣,殷蔚伯.289例局部晚期非小细胞肺癌放疗和放化综合治疗结果[J].中华放射肿瘤学杂志,2007,16(2):86-90. 被引量:30
  • 4罗扬,郝学志,张湘茹.老年晚期非小细胞肺癌的化疗可行性[J].肿瘤防治研究,2002,29(3):238-240. 被引量:28
  • 5杨志雄,梁荣,黄杰,赖振南,吴华.放化联合治疗老年非小细胞肺癌的可行性[J].肿瘤防治研究,2003,30(3):228-230. 被引量:12
  • 6Tombolini V, Bonanni A, Donato V, et al. Radiotherapy alone in elderly patients with medically inoperable stage ⅢA and Ⅱ-ⅠB non-small cell lung cancer[J]. Antican Res, 2000, 20 (6C):4829-4833.
  • 7Langer CJ, Manola J,Bernardo P, et al. Cisplatin-based therapy for elderly patients with advanced non-small cell lung cancer: implication of Eastern Cooperative Ontology Group 5592, a randomized trial[J]. J Natl Cancer Inst,2002,94(3) : 173-181.
  • 8Curran W,Scott C,Langer C,et al. Phase Ⅲ comparison of sequential vs. Concuurent chemoradiation of pts with unresected stage Ⅲ non-small cell lung cancer(NSCLC):initial report of Radiation Therapy Oncology Group(RTOG)9410. Pro[J]. Am Soc Clin Oncol, 2000,19(abstract 1891 ).
  • 9Movsas B,Scott C,Sause W,et al. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a qualityadjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies[J]. Int J Radiat Oncol Bio Phys, 1999,45(5) : 1143-1149.
  • 10Schild SE, Stella PJ,Geyer SM, et al. The outcome of combined-modality therapy for stage Ⅲ non-small cell lung cancer in the elderly[J]. J Clin Oncol, 2003,21 (17) : 3201-3206.

二级参考文献33

  • 1[1]Egorin MJ. Cancer pharmacology in the elderly. Semin Oncol,1993,20(1):43-49.
  • 2[2]Vose JM. Cytokine use in the older patient.Semin Oncol,1995,22(1 suppll):6-8.
  • 3[3]Cohen HJ.Geriatric principles of treatment applied to medical oncology .an overview.Semin Oncol,1995,22(1 sup.):1-2.
  • 4[4]Oshita F,Kurata T,KasaiT,et al. Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions. Jpn.J.Cancer Res,1995,86(12):1198-1202.
  • 5[5]Sweebey CJ, Sabdker AB. Treatment of advanced (stageⅢ andⅣ) non-small cell lung cancer.Curr Probl Cancer,1998,22(2):87-132.
  • 6Reckzeh B, Merte H, Pfluger KH, et al. Severe lymphocgfopenia and intertitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer[J]. J Clin Oneol,1996,14(4):1071-1076.
  • 7Choy H, Yee L, Cole BF, Combined-modality therapy for advanced non-small-cell lung cancer: paclitaxel and theracic irradiation[J].Semin Oncol, 1995,22(15sup):38-44.
  • 8Cohen HJ. Geriatric principles of threatment applied to medical oncology. An overview[J]. Senim Oncol, 1995, 22(lsup):1-2.
  • 9Montazeri A, Gillis PR, Mcewen J. Quality of life in patients with lung cancer: a review of literature from 1970 to 1995. Chest 1998; 113(2): 467 -81
  • 10Vodoljak E, Misek, Sapunar D, et al. Survial analysis of untreated patients with non-small cell lung cancer. Chest 1994: 106(6): 1997

共引文献64

同被引文献54

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部